Newsroom

Neway with Quest Diagnostics® is Changing the Dialysis Industry for the Better

Quest Diagnostics (DGX) to Boost Lab Services with New Pact

LITTLETON, Colo., Oct. 5, 2023 /PRNewswire/ — Neway, LLC, the U.S. leader in value-based dialysis lab care, today announced a strategic lab services arrangement with Quest Diagnostics (NYSE: DGX) that aims to accelerate dialysis laboratory testing and reduce the laboratory costs of dialysis programs for patients with end-stage renal disease (ESRD). Under the terms of…

Neway Forms Lab Services Agreement with Quest Diagnostics to Speed Quality Testing

LITTLETON, Colo., Oct. 5, 2023 /PRNewswire/ — Neway, LLC, the U.S. leader in value-based dialysis lab care, today announced a strategic lab services arrangement with Quest Diagnostics (NYSE: DGX) that aims to accelerate dialysis laboratory testing and reduce the laboratory costs of dialysis programs for patients with end-stage renal disease (ESRD). Under the terms of…

Neway Forms Lab Services Agreement with Quest Diagnostics to Speed Quality ESRD Testing

Neway Forms Lab Services Agreement with Quest Diagnostics to Speed Quality ESRD Testing

https://newsroom.questdiagnostics.com/2023-10-05-Neway-Forms-Lab-Services-Agreement-with-Quest-Diagnostics-to-Speed-Quality-ESRD-Testing” rel=”noopener” target=”_blank”>Neway Form Lab Service Agreement with Quest Diagnostics